Combination - Patents

Combination

Agent: Novartis Corporate Intellectual Property - East Hanover, NJ, US
Inventors: Malcolm Allison, Marjorie Regan Gatlin
Class: 514342000 (USPTO)
Related Patents: Drug, Bio-affecting And Body Treating Compositions, Designated Organic Active Ingredient Containing (doai), Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai, Hetero Ring Is Six-membered Consisting Of One Nitrogen And Five Carbon Atoms, Additional Hetero Ring Containing, Ring Nitrogen In The Additional Hetero Ring (e.g., Oxazole, Etc.), Ring Sulfur In The Additional Hetero Ring
#20060089389
04/27/06
(i) an AT1-receptor antagonist or a pharmaceutically acceptable salt thereof; (ii) (a) an insulin secretion enhancer or a pharmaceutically acceptable salt thereof or (b) an insulin sensitizer or a pharmaceutically acceptable salt thereof; and, in case of a pharmaceutical composition, a pharmaceutically acceptable carrier. The present invention relates to a combination, especially a pharmaceutical composition, comprising as active ingredients
[0001] The present invention relates to a combination, especially a pharmaceutical composition, comprising as active ingredients [0002] (i) an AT.sub.1-receptor antagonist or a pharmaceutically acceptable salt thereof; [0003] (ii) (a) an insulin secretion enhancer or a pharmaceutically acceptable salt thereof or [0004] (b) an insulin sensitizer or a pharmaceutically acceptable salt thereof; and, [0005] in case of a pharmaceutical composition, a pharmaceutically acceptable carrier.
Complete article is available online.